206 related articles for article (PubMed ID: 21072169)
21. In vitro selection of high-affinity DNA aptamers for streptavidin.
Wang C; Yang G; Luo Z; Ding H
Acta Biochim Biophys Sin (Shanghai); 2009 Apr; 41(4):335-40. PubMed ID: 19352549
[TBL] [Abstract][Full Text] [Related]
22. Cell-SELEX based selection and optimization of DNA aptamers for specific recognition of human cholangiocarcinoma QBC-939 cells.
Wan J; Ye L; Yang X; Guo Q; Wang K; Huang Z; Tan Y; Yuan B; Xie Q
Analyst; 2015 Sep; 140(17):5992-7. PubMed ID: 26181902
[TBL] [Abstract][Full Text] [Related]
23. Selection of DNA aptamers for ovarian cancer biomarker HE4 using CE-SELEX and high-throughput sequencing.
Eaton RM; Shallcross JA; Mael LE; Mears KS; Minkoff L; Scoville DJ; Whelan RJ
Anal Bioanal Chem; 2015 Sep; 407(23):6965-73. PubMed ID: 25863801
[TBL] [Abstract][Full Text] [Related]
24. Developing aptamer probes for acute myelogenous leukemia detection and surface protein biomarker discovery.
Yang M; Jiang G; Li W; Qiu K; Zhang M; Carter CM; Al-Quran SZ; Li Y
J Hematol Oncol; 2014 Jan; 7():5. PubMed ID: 24405684
[TBL] [Abstract][Full Text] [Related]
25. Using live cells to generate aptamers for cancer study.
Meng L; Sefah K; Colon DL; Chen H; O'Donoghue M; Xiong X; Tan W
Methods Mol Biol; 2010; 629():355-67. PubMed ID: 20387161
[TBL] [Abstract][Full Text] [Related]
26. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
[TBL] [Abstract][Full Text] [Related]
27. Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method.
Hasegawa H; Sode K; Ikebukuro K
Biotechnol Lett; 2008 May; 30(5):829-34. PubMed ID: 18175068
[TBL] [Abstract][Full Text] [Related]
28. Generating aptamers for recognition of virus-infected cells.
Tang Z; Parekh P; Turner P; Moyer RW; Tan W
Clin Chem; 2009 Apr; 55(4):813-22. PubMed ID: 19246617
[TBL] [Abstract][Full Text] [Related]
29. Production of aptamers by cell-SELEX and their applications in cancer biomarker identification.
Zhao J; He J; Zhong L; Huang Y; Zhao Y
Discov Med; 2020; 29(158):159-167. PubMed ID: 33007191
[TBL] [Abstract][Full Text] [Related]
30. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
[TBL] [Abstract][Full Text] [Related]
31. Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapy.
Mahlknecht G; Sela M; Yarden Y
Methods Mol Biol; 2015; 1317():3-15. PubMed ID: 26072398
[TBL] [Abstract][Full Text] [Related]
32. From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors.
Cibiel A; Quang NN; Gombert K; Thézé B; Garofalakis A; Ducongé F
PLoS One; 2014; 9(1):e87002. PubMed ID: 24489826
[TBL] [Abstract][Full Text] [Related]
33. Cancer protein biomarker discovery based on nucleic acid aptamers.
Xiong H; Yan J; Cai S; He Q; Peng D; Liu Z; Liu Y
Int J Biol Macromol; 2019 Jul; 132():190-202. PubMed ID: 30926499
[TBL] [Abstract][Full Text] [Related]
34. The efficient cell-SELEX strategy, Icell-SELEX, using isogenic cell lines for selection and counter-selection to generate RNA aptamers to cell surface proteins.
Takahashi M; Sakota E; Nakamura Y
Biochimie; 2016 Dec; 131():77-84. PubMed ID: 27693080
[TBL] [Abstract][Full Text] [Related]
35. Cell-SELEX, an Effective Way to the Discovery of Biomarkers and Unexpected Molecular Events.
Bing T; Zhang N; Shangguan D
Adv Biosyst; 2019 Dec; 3(12):e1900193. PubMed ID: 32648677
[TBL] [Abstract][Full Text] [Related]
36. Selection and characterization of DNA aptamer for metastatic prostate cancer recognition and tissue imaging.
Duan M; Long Y; Yang C; Wu X; Sun Y; Li J; Hu X; Lin W; Han D; Zhao Y; Liu J; Ye M; Tan W
Oncotarget; 2016 Jun; 7(24):36436-36446. PubMed ID: 27183906
[TBL] [Abstract][Full Text] [Related]
37. One round of SELEX for the generation of DNA aptamers directed against KLK6.
Arnold S; Pampalakis G; Kantiotou K; Silva D; Cortez C; Missailidis S; Sotiropoulou G
Biol Chem; 2012 Apr; 393(5):343-53. PubMed ID: 22505517
[TBL] [Abstract][Full Text] [Related]
38. Theoretical modeling of masking DNA application in aptamer-facilitated biomarker discovery.
Cherney LT; Obrecht NM; Krylov SN
Anal Chem; 2013 Apr; 85(8):4157-64. PubMed ID: 23480390
[TBL] [Abstract][Full Text] [Related]
39. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
[TBL] [Abstract][Full Text] [Related]
40. Identification of cell membrane protein stress-induced phosphoprotein 1 as a potential ovarian cancer biomarker using aptamers selected by cell systematic evolution of ligands by exponential enrichment.
Van Simaeys D; Turek D; Champanhac C; Vaizer J; Sefah K; Zhen J; Sutphen R; Tan W
Anal Chem; 2014 May; 86(9):4521-7. PubMed ID: 24654750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
